ABSTRACT
Alzheimer’s disease (AD) is the most common form of agerelated neurodegenerative disorders. The pathogenesis of
these and other neurodegenerative diseases have remained unclear, and effective treatments are currently lacking. However, recent studies from three diverse disciplines, neuropathology, genetics, and biophysics, have begun to converge on novel targets for therapeutic attack.
